🇺🇸 FDA
Pipeline program

CNTY-101

CNTY-101-151-01

Phase 1 mab active

Quick answer

CNTY-101 for Systemic Lupus Erythematosus is a Phase 1 program (mab) at Century Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Century Therapeutics
Indication
Systemic Lupus Erythematosus
Phase
Phase 1
Modality
mab
Status
active

Clinical trials